» Articles » PMID: 20498757

The Expressions of Inflammatory Factors and Tissue Inhibitor of Matrix Metalloproteinase-2 in Human Chronic Periodontitis with Type 2 Diabetes Mellitus

Overview
Specialty Dentistry
Date 2010 May 26
PMID 20498757
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to observe and quantify the expression of interleukin-4 (IL-4), interferon-gamma (IFN-gamma), and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in the gingival tissue of patients with type 2 diabetes mellitus (DM) and healthy adults with chronic periodontitis.

Methods: Twelve patients with type 2 DM and chronic periodontitis (Group 3), twelve patients with chronic periodontitis (Group 2), and twelve healthy individuals (Group 1) were included in the study. Clinical criteria of gingival (sulcus bleeding index value, probing depths) and radiographic evidences of bone resorption were divided into three groups. The concentrations of cytokines were determined by a western blot analysis and compared using one-way ANOVA followed by Tukey's test.

Results: The expression levels of IFN-gamma and TIMP-2 showed an increasing tendency in Groups 2 and 3 when compared to Group 1. On the other hand, the expression of IL-4 was highest in Group 1.

Conclusions: The findings suggest that IFN-gamma and TIMP-2 may be involved in the periodontal inflammation associated with type 2 DM. IL-4 may be involved in the retrogression of the periodontal inflammation associated with type 2 DM.

Citing Articles

Effect of endodontic treatment on clinical outcome in type 2 diabetic patients with apical periodontitis.

Wang S, Wang X, Bai F, Shi X, Zhou T, Li F Heliyon. 2023; 9(3):e13914.

PMID: 36925517 PMC: 10011187. DOI: 10.1016/j.heliyon.2023.e13914.


Expression of Inflammatory Mediators in Periodontitis Over Established Diabetes: an Experimental Study in Rats.

Choubaya C, Chahine N, Aoun G, Anil S, Zalloua P, Salameh Z Med Arch. 2022; 75(6):436-443.

PMID: 35169371 PMC: 8802681. DOI: 10.5455/medarh.2021.75.436-443.


Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis.

Peniche-Palma D, Carrillo-Avila B, Sauri-Esquivel E, Acosta-Viana K, Esparza-Villalpando V, Pozos-Guillen A Biomed Res Int. 2019; 2019:5613514.

PMID: 31355267 PMC: 6634279. DOI: 10.1155/2019/5613514.


Crestal Bone Loss Around Submerged and Non-Submerged Dental Implants in Individuals with Type-2 Diabetes Mellitus: A 7-Year Prospective Clinical Study.

Zahrani S, Al Mutairi A Med Princ Pract. 2018; 28(1):75-81.

PMID: 30396170 PMC: 6558320. DOI: 10.1159/000495111.

References
1.
Goldberg G, Marmer B, Grant G, Eisen A, Wilhelm S, He C . Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A. 1989; 86(21):8207-11. PMC: 298249. DOI: 10.1073/pnas.86.21.8207. View

2.
Gorska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K . Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol. 2004; 30(12):1046-52. DOI: 10.1046/j.0303-6979.2003.00425.x. View

3.
Reynolds J, Hembry R, Meikle M . Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res. 1994; 8(2):312-9. DOI: 10.1177/08959374940080022701. View

4.
Gemmell E, Seymour G . Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004; 35:21-41. DOI: 10.1111/j.0906-6713.2004.003557.x. View

5.
Larivee J, Sodek J, Ferrier J . Collagenase and collagenase inhibitor activities in crevicular fluid of patients receiving treatment for localized juvenile periodontitis. J Periodontal Res. 1986; 21(6):702-15. DOI: 10.1111/j.1600-0765.1986.tb01508.x. View